Aktana Launches Next Generation of its Contextual Intelligence Engine to Accelerate Enterprise-Wide AI Adoption
06 oct. 2021 07h24 HE | Aktana
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE)...
7 Hills Logo.png
Texas Heart Institute, University of Texas Medical Branch (UTMB) and 7 Hills Pharma Pioneer Significant Vaccine Research
01 oct. 2021 14h59 HE | 7 Hills Pharma
HOUSTON, TX., Oct. 01, 2021 (GLOBE NEWSWIRE) -- The Texas Heart Institute has announced that a research team led by its Vice President for Research Dr. Darren Woodside and Dr. Peter Vanderslice, of...
FourKites Named a Leader in Pharmaceutical Supply Chain Visibility Report
30 sept. 2021 07h30 HE | FourKites
CHICAGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- FourKites®, the world’s leading real-time supply chain visibility platform, announced that it has been named a Leader in CB Insights’ recent...
NJ Labs Celebrates 85 Years In the Testing Industry
29 sept. 2021 10h26 HE | NJ Labs
NEW BRUNSWICK, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- While Dr. David Levowitz was at Rutgers University, he saw a growing need to promote quality in dairy and food production, so he created New...
Knight Therapeutics firma acuerdo de exclusividad con Incyte para el suministro y la distribución de Tafasitamab y Pemigatinib en Latinoamérica
23 sept. 2021 07h30 HE | Knight Therapeutics
MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), una compañía panamericana (ex- Estados Unidos) de especialidad farmacéutica, anunció hoy la firma de un...
Thérapeutique Knight conclut une entente exclusive avec Incyte pour l’approvisionnement et la distribution de tafasitamab et de pemigatinib en Amérique latine
23 sept. 2021 07h30 HE | Thérapeutique Knight inc.
MONTRÉAL, 23 sept. 2021 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), société pharmaceutique spécialisée panaméricaine (ex-ÉU) a annoncé aujourd’hui...
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America
23 sept. 2021 07h30 HE | Knight Therapeutics
MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, today announced that it has entered into a...
Knight Therapeutics celebra acordo exclusivo de fornecimento e distribuição com a Incyte para Tafasitamabe e Pemigatinibe na América Latina
23 sept. 2021 07h30 HE | Knight Therapeutics
MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- A Knight Therapeutics Inc. (TSX: GUD) (“Knight”), uma empresa farmacêutica especializada panamericana (ex-EUA), anunciou hoje que celebrou um acordo...
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
21 sept. 2021 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
New Report Shows 89% of Diabetics Worry About Broken Insulin Vials
15 sept. 2021 09h00 HE | SiO2 Materials Science
AUBURN, Ala., Sept. 15, 2021 (GLOBE NEWSWIRE) -- SiO2 Materials Science, a privately owned U.S.-based advanced materials science company, today released the findings from its new report: The Impact...